[ad_1]
Moderna’s coronavirus vaccine is safe and effective, the United States Food and Drug Administration (FDA) wrote in its analysis on Tuesday.
It was also stated that
The vaccine is expected to be approved in the United States urgently in a few days.
The vaccine, developed by a US biotech company, “has no special safety concerns that would prevent it from issuing an emergency clearance,” FDA experts wrote in their study, who will meet Thursday to decide on the authorization.
According to Moderna, the results of the last phase of clinical trials suggest that
the vaccine protects against asymptomatic infections after the first dose.
If FDA experts approve Moderna’s vaccine, which is estimated to be 94.1 percent effective, the vaccine will be part of the largest vaccination campaign in the United States to date, following a vaccine developed. by Pfizer / BioNTech.
US authorities plan to vaccinate about 20 million Americans by the end of December and 100 million by the end of March.
The United States has purchased a total of 200 million doses of the Moderna vaccine, half of which is expected to be marketed in the second quarter of 2021 alone. Washington has linked an additional 100 million doses of vaccine from a product jointly developed by the American pharmaceutical company Pfizer and the German biotechnology company BioNTech.
Moderna’s licensing process follows Pfizer / BioNTech, which was licensed by the FDA last Friday.
Easier to store
Virologist Gábor Kemenesi, winner of the Junior Prima award, responded to the news on Facebook. He wrote that the drug is similar to the Pfizer / BioNTech vaccine, but
that it is sufficient to store at -20 degrees Celsius, unlike the other vaccine, which in turn must be stored at -70 degrees.
This simplifies logistics, as it can be stored without special refrigeration equipment, the expert added.
[ad_2]
